InterventionsHuman trial
APOE‐specific Cognitive Effects of Levetiracetam in Mid‐Age Adults
AAIC 2025 Abstract
Abstract
Background: Low‐dose levetiracetam is under investigation as a potential treatment for slowing the progression of Alzheimer’s Disease (AD).
The paper
Brighton and Sussex Medical School · University of Sussex
AAIC 2025 Abstract · 25 Dec 2025 · CC BY
Presented at AAIC 2025
